04:11 AM EDT, 07/15/2026 (MT Newswires) -- BioPharma Credit (BPCP.L, BPCR.L) will invest up to $45 million in Kestra Medical Technologies under a three-tranche senior secured loan deal. The British life sciences debt investment trust said Wednesday that the loan, which will mature in July 2031, will carry an annual interest rate of a three-month Secured Overnight Financing Rate, or SOFR, plus 5.50%, subject to a 3.25% SOFR floor. BioPharma Credit said the investments for the wearable medical device and digital healthcare company will be subject to customary requirements. Additionally, the company's BioPharma Credit Investments V (Master) unit will also act as a collateral agent for an additional $105 million investment.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.